Beam Therapeutics (BEAM)
NASDAQ:BEAM
US Market
Holding BEAM?
Track your performance easily

Beam Therapeutics (BEAM) Technical Analysis

1,237 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
5Neutral
5Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
Beam Therapeutics’s (BEAM) Moving Averages Convergence Divergence (MACD) indicator is -0.09, suggesting Beam Therapeutics is a Sell.
Beam Therapeutics’s (BEAM) 20-Day exponential moving average is 25.25, while Beam Therapeutics’s (BEAM) share price is $25.58, making it a Buy.
Beam Therapeutics’s (BEAM) 50-Day exponential moving average is 25.53, while Beam Therapeutics’s (BEAM) share price is $25.58, making it a Buy.

Beam Therapeutics (BEAM) Pivot Points

Sep 20, 2024, 09:31 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
22.56
23.76
24.63
25.84
26.71
27.91
28.79
Fibonacci
23.76
24.55
25.04
25.84
26.63
27.12
27.91
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Beam Therapeutics (BEAM) Moving Averages

Sep 20, 2024, 09:31 PM
Period
Simple
Exponential
MA5
25.81Buy
25.58Buy
MA10
24.79Buy
25.28Buy
MA20
25.24Buy
25.25Buy
MA50
26.31Sell
25.53Buy
MA100
25.01Buy
25.83Buy
MA200
27.33Sell
26.41Sell
Beam Therapeutics’s (BEAM) 10-Day exponential moving average is 25.28, while Beam Therapeutics’s (BEAM) share price is $25.58, making it a Buy.
Beam Therapeutics’s (BEAM) 100-Day exponential moving average is 25.83, while Beam Therapeutics’s (BEAM) share price is $25.58, making it a Buy.
Beam Therapeutics’s (BEAM) stock price is $25.58 and Beam Therapeutics’s (BEAM) 50-day simple moving average is 26.31, creating a Sell signal.
Beam Therapeutics’s (BEAM) stock price is $25.58 and Beam Therapeutics’s (BEAM) 100-day simple moving average is 25.01, creating a Buy signal.
Beam Therapeutics’s (BEAM) stock price is $25.58 and Beam Therapeutics’s (BEAM) 200-day simple moving average is 27.33, creating a Sell signal.

Beam Therapeutics (BEAM) Technical Indicators

Sep 20, 2024, 09:31 PM
Name
Value
Implied Action
RSI (14)
54.11
Neutral
STOCH (9,6)
69.39
Neutral
STOCHRSI (14)
59.28
Neutral
MACD (12,26)
-0.09
Sell
ADX (14)
14.55
Buy
Williams %R
-29.05
Buy
CCI (14)
59.73
Neutral
ATR (14)
1.41
-
Ultimate Oscillator
49.84
Neutral
ROC
-2.98
Sell
Beam Therapeutics’s (BEAM) Relative Strength Index (RSI) is 54.11, creating a Neutral signal.
Beam Therapeutics’s (BEAM) Trend Strength Indicator (ADX) is 14.55, creating a Buy signal.
Beam Therapeutics’s (BEAM) Commodity Channel Index (CCI) is 59.73, creating a Neutral signal.
Beam Therapeutics’s (BEAM) Price Rate of Change (ROC) is -2.98, creating a Sell signal.

FAQ

Is BEAM a Buy, Hold, or Sell?
Based on BEAM’s technical indicators, BEAM is a Buy.
    What is BEAM’s RSI (14)?
    BEAM’s RSI (14) is 54.11, which suggests BEAM is a Neutral.
      What is BEAM’s MACD?
      BEAM’s MACD is -0.09, which suggests BEAM is a Sell.
        What is BEAM’s 5-day moving average?
        BEAM’s 5-day moving average is 25.81, which suggests BEAM is a Buy.
          What is BEAM’s 20-day moving average?
          BEAM 20-day moving average is 25.24, which suggests BEAM is a Buy.
            What is BEAM’s 50-day moving average?
            BEAM’s 50-day moving average is 26.31, which suggests BEAM is a Sell.
              What is BEAM’s 200-day moving average?
              BEAM’s 200-day moving average is 27.33, which suggests BEAM is a Sell.
                What is BEAM’s Williams % R (14)?
                BEAM’s Williams % R (14) is -29.05, which suggests BEAM is a Buy.
                  What is BEAM’s CCI (14)?
                  BEAM’s CCI (14) is 59.73, which suggests BEAM is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis